| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/02/1996 | CA2200427A1 Receptor for a bacillus thuringiensis toxin |
| 05/01/1996 | EP0709460A1 Coccidiosis poultry vaccine |
| 05/01/1996 | EP0709459A2 Modified biological material |
| 05/01/1996 | EP0709455A1 Monoclonal antibody to human glicentin, hybridoma for producing said antibody and assay method for human glicentin using said antibody |
| 05/01/1996 | EP0709397A1 p53as Protein and antibody therefor |
| 05/01/1996 | EP0709396A1 Gamma T cell receptor and methods for detection |
| 05/01/1996 | EP0708922A1 Identification of ligands by selective amplification of cells transfected with receptors |
| 05/01/1996 | EP0708877A1 Method for repairing a combustion chamber assembly |
| 05/01/1996 | EP0708832A1 Helicobacter pylori haemagglutinin/protease protein, nucleic acid encoding therefor and antibodies specific thereto |
| 05/01/1996 | EP0708831A1 Density enhanced protein tyrosine phosphatases |
| 05/01/1996 | EP0708830A1 $i(BACILLUS THURINGIENSIS) ISOLATES AND TOXINS |
| 05/01/1996 | EP0708656A1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 05/01/1996 | EP0708655A1 Methods of using insulin-like growth factor binding proteins |
| 05/01/1996 | EP0708592A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence |
| 05/01/1996 | EP0491031B1 Cdr grafted anti-cea antibodies and their production |
| 05/01/1996 | EP0441917B1 Pokeweed antiviral protein - monoclonal antibody conjugates |
| 05/01/1996 | CN1121732A A method for hydrolysing proteins |
| 05/01/1996 | CN1121724A Extraction of cell-bound protein from bordetella |
| 05/01/1996 | CN1031714C Process for preparing urinary follicle stimulating hormone |
| 05/01/1996 | CA2161480A1 Monoclonal antibody to human glicentin, hybridoma for producing said antibody and assay method for human glicentin using said antibody |
| 04/30/1996 | US5512661 Provides for nucleic acids encoding chimeric neurotrophic factors; for targeting active compounds to cells responsive to neurotropic factor |
| 04/30/1996 | US5512658 Pseudomonas exotoxins (PE) and conjugates thereof having lower animal toxicity with high cytocidal activity through substitution of positively charged amino acids |
| 04/30/1996 | US5512550 Method for inhibiting angiogenesis with modified platelet factor-4 and cleaved platelet factor-4 |
| 04/30/1996 | US5512484 Carrot 16 KD protein, gene coding for said protein and plasmid containing said gene |
| 04/30/1996 | US5512473 Max-interacting proteins and related molecules and methods |
| 04/30/1996 | US5512460 Glia activating factor and its production |
| 04/30/1996 | US5512459 Transpeptization by contacting peptide and addition unit with thrombin to cleave leaving unit from core at enzyme cleavage site |
| 04/30/1996 | US5512457 Cytokine designated elk ligand |
| 04/30/1996 | US5512455 Atrial natriuretic peptide receptor protein |
| 04/30/1996 | US5512443 Second generation monoclonal antibodies having binding specificity to TAG-72 and human carcinomas and methods for employing the same |
| 04/30/1996 | US5512288 Administering culture product from medium containing bile |
| 04/30/1996 | US5512283 Methods for the selective suppression of an immune response to dust mite der Pi |
| 04/25/1996 | WO1996012185A1 Method for screening compositions |
| 04/25/1996 | WO1996012033A1 Polycystic kidney disease gene |
| 04/25/1996 | WO1996012032A1 Process for manufacturing cyclosporin a by highly productive fusant strain |
| 04/25/1996 | WO1996012031A1 Process for preparing cyclosporin a |
| 04/25/1996 | WO1996012025A1 TRANSGENIC NONHUMAN ANIMAL HAVING FUNCTIONALLY DISRUPTED INTERLEUKIN-1β CONVERTING ENZYME GENE |
| 04/25/1996 | WO1996012024A1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 04/25/1996 | WO1996012020A2 Hemoglobin receptors from neisseriae |
| 04/25/1996 | WO1996012019A2 Her4 human receptor tyrosine kinase or the epidermal growth factor receptor family |
| 04/25/1996 | WO1996012017A1 Gene participating in apoptosis |
| 04/25/1996 | WO1996011955A1 Antigen-binding fusion proteins |
| 04/25/1996 | WO1996011952A1 Method for purifying keratinocyte growth factors |
| 04/25/1996 | WO1996011951A2 Keratinocyte growth factor analogs |
| 04/25/1996 | WO1996011950A1 Method of treating diabetes mellitus using kgf |
| 04/25/1996 | WO1996011949A2 Analogs of keratinocyte growth factor |
| 04/25/1996 | WO1996011947A1 Materials for the production of nanometer structures and use thereof |
| 04/25/1996 | WO1996011706A1 Use of flea proteases and protease inhibitors to protect animals from flea infestation |
| 04/25/1996 | WO1996011696A1 Screening assay for anti-hiv drugs |
| 04/25/1996 | WO1996011664A2 Nsk2 a muscle receptor tyrosine kinase |
| 04/25/1996 | WO1996004557A3 Target specific screens and their use for discovering small organic molecular pharmacophores |
| 04/25/1996 | CA2203116A1 Hemoglobin receptors from neisseriae |
| 04/25/1996 | CA2202628A1 Apoptosis-associated gene |
| 04/25/1996 | CA2202622A1 Use of protease inhibitors and protease vaccines to protect animals from flea infestation, and flea protease proteins, nucleic acid molecules and uses thereof |
| 04/25/1996 | CA2202533A1 Her4 human receptor tyrosine kinase |
| 04/25/1996 | CA2202474A1 Materials for the production of nanometer structures and use thereof |
| 04/25/1996 | CA2202283A1 Polycystic kidney disease gene |
| 04/25/1996 | CA2202048A1 Screening assay for anti-hiv drugs |
| 04/24/1996 | EP0707651A1 METHODS AND COMPOSITIONS FOR DETECTION OF $i(SALMONELLA) |
| 04/24/1996 | EP0707650A1 Process for producing relaxin |
| 04/24/1996 | EP0707649A1 Cisplatin resistance gene and uses therefor |
| 04/24/1996 | EP0707647A1 Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis |
| 04/24/1996 | EP0707641A1 An enzyme with protease activity |
| 04/24/1996 | EP0707634A1 New stromal cell lines from human bone marrow and their use |
| 04/24/1996 | CN1121367A Solar venturi turbine |
| 04/24/1996 | CN1121357A Hepatitis B escape mutant specific binding molecules |
| 04/24/1996 | CN1121312A Chlamydia vaccine and process |
| 04/23/1996 | US5510466 Scavenger receptor protein and antibody thereto |
| 04/23/1996 | US5510462 IL-1βprotein precursor |
| 04/23/1996 | US5510459 Glucagon antagonists |
| 04/23/1996 | US5510259 Isolated, purified dna having nucleotide sequence coding for said molecule |
| 04/23/1996 | US5510256 Genetically engineered dna sequences which do not code for a lymphocyte membrane polypeptide |
| 04/23/1996 | US5510249 Fusion of signal peptide, a leader peptide, a heterogenous protein or polypeptide; genetic engineering |
| 04/23/1996 | US5510240 Method of screening a peptide library |
| 04/23/1996 | CA1338262C Antitumor antibiotic kedarcidin |
| 04/23/1996 | CA1338260C Human protein s, a plasma protein regulator of hemostasis |
| 04/18/1996 | WO1996011277A1 Microorganisms as therapeutic delivery systems |
| 04/18/1996 | WO1996011274A1 Chimeric papillomavirus-like particles |
| 04/18/1996 | WO1996011273A1 Papillomavirus vaccine |
| 04/18/1996 | WO1996011272A2 Papilloma virus-like particles, fusion proteins and process for producing the same |
| 04/18/1996 | WO1996011271A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/18/1996 | WO1996011269A2 Tie-2 ligands, methods of making and uses thereof |
| 04/18/1996 | WO1996011267A1 Dna coding for a zinc finger protein, a zinc finger protein and the use thereof |
| 04/18/1996 | WO1996011263A1 Enzyme for cleavage of the anchor region of surface proteins from gram positive bacteria |
| 04/18/1996 | WO1996011260A1 Patched genes and their use |
| 04/18/1996 | WO1996011214A1 Peptides and pharmaceutical compositions comprising them |
| 04/18/1996 | WO1996011212A1 Novel receptor-type tyrosine kinase ligand |
| 04/18/1996 | WO1996011207A1 Compositions and methods for interfering with hepatitis b virus infection |
| 04/18/1996 | WO1996011020A1 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient |
| 04/18/1996 | WO1996011013A1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 04/18/1996 | WO1996010911A1 Cytokine designated lerk-6 |
| 04/18/1996 | WO1996007739A3 Interleukin-1 type 3 receptors |
| 04/18/1996 | WO1996001317A3 Mammalian peroxisome proliferator-activated receptors and uses thereof |
| 04/18/1996 | DE19507166C1 Antibodies specific for fusion polypeptide(s) contg. a histidine component |
| 04/18/1996 | CA2201935A1 Peptides and pharmaceutical compositions comprising them |
| 04/18/1996 | CA2201721A1 Microorganisms as therapeutic delivery systems |
| 04/18/1996 | CA2201616A1 Enzyme for cleavage of the anchor region of surface proteins from gram positive bacteria |
| 04/17/1996 | EP0707071A1 Recombinant vectors derived from adenovirus for use in gene therapy |
| 04/17/1996 | EP0707069A2 Process for preparing virus-resistant transgenic plant |
| 04/17/1996 | EP0706799A2 Immunoconjugates II |